Drug improves mobility for some MS patients
Friday, February 27, 2009 - 06:43
in Health & Medicine
The experimental drug fampridine (4-aminopyridine) improves walking ability in some individuals with multiple sclerosis (MS). That is the conclusion of a multi-center Phase 3 clinical trial, the results of which were published today in the journal The Lancet.